UCSF 18th Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2021

Include: 2 videos 1 pdf, size: 8.77 GB

Overview

Now in its 18th year, and presented by the department of epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. Specific topics will include the cell biology of osteoporosis, bone biomechanics, endocrine and nutrition aspects of osteoporosis, and advances in skeletal imaging. The course will also critically review current treatment options and preview new treatments. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis.

Educational Objectives

An attendee completing this course will be able to:

• Provide appropriate pharmacological treatment for osteoporosis, including the use of new therapies;
• Evaluate the benefits and risks of continuing long-term antiresorptive and anabolic osteoporosis therapy and determine optimal treatment duration;
• Evaluate in whom and when a drug holiday would be appropriate for patients on bisphosphonates;
• Choose appropriate follow-on therapy for the anabolic therapies teriparatide, abaloparatide and romosozumab;
• Understand bone health issues in transgender patients.

Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

July 15 Part 1.mp4 ( 5 hours)
July 15 Part 2.mp4 ( 1 hours)
MEP22001_Syllabus.pdf

*Detail:

Thursday, July 15, 2021

ANTIRESORPTIVE TREATMENT
8:00am Zoom Registration and Login
8:30 Bisphosphonate Efficacy: New Strategies to Maximize Fracture Risk Reduction Richard Eastell, MD, FRCP
8:50 Bisphosphonate Duration and Drug Holidays: Maximize Benefits and Minimize Risk Dennis M. Black, PhD
9:25 Q&A
9:40 Long-Term Treatment With and Following Denosumab Deborah E. Sellmeyer, MD
10:10 Q&A
10:20 Break

ANABOLIC TREATMENT
10:35 Anabolic Agents: Efficacy and Safety Clifford J. Rosen, MD
11:05 Incorporating Anabolic Treatments into Osteoporosis Regimens Anne L. Schafer, MD
11:30 Q&A
11:45am Lunch Break

SPECIAL TOPICS IN OSTEOPOROSIS
12:30pm Metabolic Bone Disease in the Setting of Chronic Kidney Disease Paul D. Miller, MD, HDSc (HON)
1:00 Q&A
1:10 Stress Fractures in Premenopausal Women and Young Men Mary L. Bouxsein, PhD
1:30 Q&A
1:40 DXA Interpretation and Pitfalls Deborah Sellmeyer, MD
2:10 Q&A
2:20 Break
2:35 Racial Differences and Disparities in Osteoporosis Care Nicole C. Wright, PhD, MPH
3:00 Q&A
3:10 Clinical Roundtable: Q&A with a Panel of Physicians Deborah E. Sellmeyer, MD Anne L. Schafer, MD Clifford J. Rosen, MD  Steven T. Harris, MD, FACP, FASBMR Dolores M. Shoback, MD
3:45 Adjourn